Biography and Research Information
OverviewAI-generated summary
Haya Safar's research focuses on exploring vulnerabilities within biological systems, particularly concerning cancer and immune responses. Safar has investigated the Kras-p53 mutational interface, seeking to identify potential therapeutic targets for cancer treatment. Additionally, Safar has examined the temporal aspects of immune-related adverse events (irAEs) and their underlying mechanistic implications, contributing to a better understanding of treatment side effects in patients. Safar's work is supported by collaborations with researchers at the University of Arkansas for Medical Sciences, including Farah Mazahreh and Nishanth Thalambedu, with whom Safar has co-authored multiple publications. Safar's scholarly output includes two publications, indicating recent activity in these research areas.
Metrics
- Publications: 2
Selected Publications
-
Abstract B009: Exploring the putative Kras-p53 mutational interface for vulnerability (2024)
-
Abstract 1177: The chronology of immune-related adverse events (irAEs)-mechanistic implications (2024)
Collaboration Network
Top Collaborators
- Abstract 1177: The chronology of immune-related adverse events (irAEs)-mechanistic implications
- Abstract B009: Exploring the putative Kras-p53 mutational interface for vulnerability
- Abstract 1177: The chronology of immune-related adverse events (irAEs)-mechanistic implications
- Abstract 1177: The chronology of immune-related adverse events (irAEs)-mechanistic implications
- Abstract B009: Exploring the putative Kras-p53 mutational interface for vulnerability
- Abstract B009: Exploring the putative Kras-p53 mutational interface for vulnerability
- Abstract B009: Exploring the putative Kras-p53 mutational interface for vulnerability
Similar Researchers
Based on overlapping research topics